Introduction
A considerable amount of information now exists concerning the processes involved in neuron death. The mechanisms of cell death following various types of necrotic insults and in certain neurodegenerative disorders are thought to include an accumulation of cytosolic calcium (Ca 2+ ) from various source. 1, 2 This change in Ca
2+
ion homeostasis then initiates a cascade of neurodegenerative events such as oxygen radical formation, cytoskeletal degradation and protein malfolding. Knowing when and how these processes occur has allowed for the development of gene therapy strategies for neuroprotective purposes. In fact, a number of studies have used neuronal gene transfer to decrease the amount of damage observed following necrotic insult. These include overexpression of a glucose transporter, 3 heat shock factor hsp72, 4 superoxide dismutase (SOD) for decreasing oxygen radical production, 5 or apoptotic process inhibitors such as Bcl-2. 6, 7 Protection in these studies was typically measured as a reduction in the number of neurons lost, or a decrease in lesion size.
Two subtle issues begin to emerge as we progress in the use of gene transfer techniques for neuroprotective purposes. First, since acute necrotic insults are not typically predictable, is it possible to introduce a gene transfer vector some time after an insult and still obtain significant protection? Second, when you save a neuron from death with gene therapy intervention, is the function of the neuron also spared? In this study we explore these two issues and find that they are interrelated. Specifically, we focused on overexpression of the calcium binding protein calbindin D 28K . A protective role for this Behavioral performance was evaluated for immediate and 1 h delay groups using a hippocampal-dependent task. Despite equivalent magnitude and pattern of sparing of neurons with the immediate and 1 h delay approaches, the delay animals took a significantly longer time after insult to return to normal performance. Gene Therapy (2001) 8, 579-585.
protein is suggested by the finding that overexpression of calbindin decreased serum withdrawal-induced degeneration 8 and decreased the damage seen after hypoglycemic and glutamatergic challenge in vitro. 9, 10 In vivo, calbindin overexpression decreased both excitotoxic and metabolic damage. 11 Our goal in the present study was to evaluate the protective capabilities of overexpression of calbindin at various time-points after excitotoxic insult as measured by reduction in neuron loss. To further our understanding of gene therapy effects on neurological function and the time-course involved for neuroprotection, we also examined the subsequent physiological function of these protected neurons as evaluated by performance on a hippocampal-dependent behavioral task.
Results
Infection of primary cultures with the calbindin vector resulted in expression of calbindin protein that covaried with expression of lacZ ( Figure 1) ; because of this covariance, and our prior demonstration of more than 98% covariance in expression between transgene and reporter gene in this vector system, 4 for all subsequent studies, we chose the methodologically easier route of quantifying reporter gene expression. Injection of the HSV vector into the hippocampus selectively infected cells of the dentate gyrus as reported previously 11, 12 ( Figure 2 ). No detectable neuron loss was observed in any hemisphere that received virus but no insult, in agreement with prior reports. 13 Unilateral hippocampal damage was induced by application of the excitotoxin kainic acid. Kainic acidinduced hippocampal damage in animals receiving the control vector with only a reporter gene was significantly greater than in animals receiving the calbindin vector at immediate (F(1,19) = 6.24, P Ͻ 0.05), 30 min (F(1,13) = 9.08, P Ͻ 0.01), and 1 h time-points (F(1,9) = 13.39, P Ͻ 0.01), but not after a 4 h delay (Figure 3 ). Similar levels of neuronal protection were seen in the immediate, 30 min delay, and 1 h delay groups (34, 45, and 40% protection compared with controls, respectively).
A separate set of animals comprising an immediate group (immed) and 1 h delay group (hour) were tested for behavioral performance on a T-maze, delayed alternation task as described in the Methods section. Briefly, animals were trained to criterion, followed by separation into groups, surgery, and post-surgical testing sessions on days 7 and 11. All animals included in the study reached the criterion of making one or no errors for 2 days before surgery. A separate group of animals was run that had no kainic acid lesions but were infected with the calbindin vector to assess the effects of surgery and HSV infection on behavioral performance. This group of animals made no errors on day 3 after surgery. While no statistically significant difference in the levels of neuronal protection was seen when the vector was administered immediately or 1 h after insult (see Figures  3 and 4) , performance on a hippocampal-dependent spatial memory task was disrupted for 1 h delay animals, but not for the immediate application group when tested 7 days after insult (F(2,24) = 3.94, P = 0.03; post hoc tests revealed differences between the immediate group and controls (P Ͻ 0.05), and between the immediate group and hour delay group (P Ͻ 0.05), but not between the hour delay group and controls; Figure 5 ). One hour delay animals reached normal performance levels only after 11 post-surgical recovery days (F(2,24) = 4.39, P = 0.028; significant differences between both 1 h delay and immediate groups and controls, P Ͻ 0.05 for both tests). Thus, although delivery of the protective vector either at the time of insult or 1 h after insult had equivalent diminution of lesion size, the 1 h delay was associated with a significant delay in normalization of behavioral performance. Potentially, this could be due to immediate delivery producing greater expression and/or a more protective pattern of expression. However, the two groups did not differ significantly in number of neurons infected (immediate group: 8962 28 infected neurons ± 3091; 1 h delay group: 11 170.8 ± 2210; P = 0.58 NS by t Gene Therapy
Figure 5 Behavioral performance on a spatial delayed alternation task among animals injected with calbindin-expressing vector at the time of the insult (immed), injected with control vector (cntrl), or injected with a calbindin-expressing vector after a 1 h delay (hour

Figure 6 Equivalent patterns of reporter gene expression for immediate (immed) and 1 h delay (hour) groups given the calbindin vector. (a) Distribution of infected neurons in the dentate gyrus along the anterior/posterior axis, as a percentage of total number of positive neurons (n = 5 per group). X axis indicates anterior/posterior coordinates relative to Bregma. (b) Distribution of infected neurons in the dentate gyrus along the medial/lateral axis, as a percentage of total number of positive neurons (n = 5 per group).
test), or in distribution of expression in the dentate gyrus along the anterior/posterior (no significant interaction between group and AP level; F(7,71) = 1.15, P = 0.346 NS) or medial/lateral axes (no significant interaction between group and ML level; F(5,29) = 1.18, P = 0.348 NS) ( Figure  6 ). Moreover, the pattern of lesion sparing did not differ between the two groups in either the anterior/posterior (no interaction between group and AP level; F(7,79) = 0.24, P = 0.98 NS) or medial/lateral axes (no interaction between group and ML level; F(2,29) = 2.157, P = 0.138 NS; Figure 7 ).
Discussion
Gene therapy via calbindin-overexpressing HSV vectors in vivo can be neuroprotective when administered immediately or 1 h after a kainic acid insult, an important prerequisite for any eventual therapeutic use of a gene transfer approach. The expression patterns induced at those two times were of similar magnitude and distribution within the hippocampus, and CA3 lesion size was decreased to a similar extent, and with a similar pattern. Despite those equivalencies, however, the delayed delivery of the protective transgene was associated with a less salutary behavioral outcome, in that it took a longer time for performance to normalize in such animals.
The first finding to consider is why, broadly, calbindin overexpression was protective at any time-point. Damage caused by the rise in intracellular Ca 2+ concentration ([Ca   2+ ] i ) after an insult such as kainic acid is dependent upon the activation of proteases, endonucleases, and the generation of reactive oxygen species.
14-17 Supplementing the Ca 2+ binding capacity of vulnerable cells by calbindin gene transfer can reduce neuron damage by interrupting the cascade of Ca 2+ -induced neurodegenerative events. In this study, infection with an amplicon-expressing calbindin in the dentate gyrus provided transsynaptic protection of area CA3 neurons from kainic acid damage. This excitotoxin may be acting on dentate presynaptic autoreceptors to facilitate the release of more glutamate into the synapse. 18 In such a scenario, excitotoxic damage of CA3 is presumably reduced by increased calbindin binding of dentate presynaptic Ca 2+ , which then reduced the amount of glutamate released.
We observed that delivering the calbindin-expressing vector after the onset of the insult could also be protective, in agreement with prior studies indicating that there is a post-insult window of protection for gene therapy interventions with other transgenes. 19, 20 At some point after an excitotoxic insult (4 h, in the present case) the cascade of neurodegenerative events reached a stage such that delivery of the calbindin-expressing vector was too late to prevent the damage that had already occurred. When coupled with the 4-6 h latency for HSV-driven protein expression, 19 this begins to define the therapeutic time-window after insult for reducing free cytosolic Ca 2+ concentrations. We then investigated the behavioral consequences of such neuroprotection. The hippocampus plays a critical role in learning and memory. Lesions of the hippocampus produce memory impairments, especially spatial memory impairments in rodents.
20, 21 The hippocampal damage caused by kainic acid in the present study was sufficient for inhibition of proper spatial or memory guided performance on the T-maze, delayed alternation task. We were also able to determine that unilateral damage is sufficient to disrupt performance of this task, without producing response perseveration correlated to the hemisphere in which hippocampal neurons were lost. The partial hippocampal damage caused by this unilateral lesion may explain why no lesioned group was at chance performance levels (as would be expected with complete hippocampal damage), but simply performed worse than the nonlesioned controls.
By 7 days after surgery, performance was normalized in the immediate group; in contrast, such normalization was not demonstrable until post-surgical day 11 in the 1 h delay group (and was never demonstrable in animals receiving the control vector). There is a precedent in the gene therapy literature for sparing of function as well as protection following acute insult models. 22, 23 In the latter study, application of either a glucose transporter vector or an anti-apoptotic Bcl-2 vector significantly reduced the damage seen following an excitotoxic insult. However, because of differences in the mechanism of protective action between the two vectors, only the glucose transporter was effective in also saving performance on a hippocampal-dependent spatial learning task. The present results extend this idea that two gene therapies (differing as to the transgene delivered, or in the timing of when a single transgene is delivered) may spare neurons from death to equal extents, but may not spare function to equal extents. Potentially, this could be due to a difference in the extent or pattern of gene expression, and/or the extent or pattern of neurons spared. However, no significant differences were observed between groups along any of these variables. Thus, neither differences in the amount or pattern of gene expression, nor differences in lesion size or location can explain the prolonged recovery time needed for delayed treatment animals.
As noted, while 1 h delay animals were impaired on the memory task 7 days after surgery (in contrast to the immediate animals), their performance eventually did normalize. Processes that might be reversibly disrupted in neurons following kainic acid treatment may include energy depletion due to the metabolic costs of Ca 2+ sequestering or extrusion, oxygen radical production, and protein synthesis inhibition. Overexpression of calbindin in cultured hippocampal neurons has been found to attenuate the decline in metabolic rate following an 583 excitotoxic challenge. 24 While calbindin overexpression may be significantly attenuating metabolic decline, it may take days for neurons to recover fully from the metabolic effects of kainic acid treatment. Those neurons that are protected from metabolic decline sooner may take less time to return to normal function. By similar logic, an earlier intervention may also make for less cumulative oxidative damage and/or inhibition of protein synthesis 25, 26 allowing for more rapid recovery after insult. Little is known, however, about the time-course of repair of oxidative damage or the restitution of protein synthesis in the hippocampus in vivo following an excitotoxic insult. Finally, mossy fiber sprouting occurs after kainic acid treatment 27 and the cumulative effects of the earlier intervention in the immediate group may facilitate this process.
Thus, while an extended time-window after insult in which to carry out gene therapy interventions has obvious clinical appeal, sparing of neurons under such delayed settings may not have the most desirable of functional outcomes. The present findings emphasize the need both to develop means for more rapid expression of transgenes following insults, as well as understand the processes that might speed the recovery of neuronal function after an insult.
Methods
Vector production HSV amplicon vectors were constructed expressing the Ca 2+ binding protein calbindin D 28K and a reporter gene. A control vector was also constructed which lacked the calbindin coding sequence but contained the reporter gene. These methods have been described in detail previously. 11 A rat calbindin cDNA clone (pBC40) was cloned into the bicistronic expression plasmid p␣22␤gal, which used the Escherichia coli lacZ gene (␤-galactosidase) as a reporter gene. This produced the vector v␣4CB␣22␤gal, with the calbindin and lacZ gene under control of the HSV ␣4 and ␣22 promoters, respectively. Plasmids were transfected into E5 cells using Lipofectamine cationic liposome. After transfection, cells were superinfected with HSV deletion mutant d120. After nearly complete cytopathic effect was reached, cells were frozen, quick thawed, and purified with sucrose gradient ultracentrifugation. This gave rise to HSV vectors and replication-deficient helper virus at titers of 2.5 × 10 7 infectious particles/ml and 2.5 × 10 7 plaque-forming units/ml, respectively. Titers of control vector and helper virus were 1.5 × 10 7 infectious particles/ml and 3.7 × 10 7 plaque-forming units/ml, respectively.
Vector expression
Co-expression from the bipromoter vectors: To verify coexpression of both calbindin and ␤gal from the bipromoter vector, Vero cells and brain sections were used. Vero cells were transfected with CB vector or control vector. Twelve hours later, cultures were fixed with acetone:-methanol (3:1; −20°C). Adjacent brain sections were fixed in 3% paraformaldehyde and 20% sucrose for 24 h. Thirty-mm brain sections were cut on a cryostat and allowed to air dry. Sections were treated with Proteinase K (1:2 dilution; Dako, Carpenteria, CA, USA) for 15 min, then washed in PBS.
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After blocking in 10% normal horse containing 2.5% Triton-X 100, cultures and sections were incubated in primary antibodies against ␤gal (mouse monoclonal, 1:1000 dilution for Vero cells and 1:250 dilution for brain sections; Sigma, St Louis, MO, USA) for 1 h at room temperature. After washing in PBS, cultures and sections were incubated for 1 h in fluorescein-conjugated goat anti-mouse antibody (1:150; Vector FI-2000, Burlingame, CA, USA). The cultures and sections were washed, and blocked in 10% normal goat serum. The second primary antibody against CaBP (rabbit polyclonal, 1:1000 dilution for Vero cells, a gift of K Baimbridge (University of British Columbia, BC, Canada), and 1:200 dilution for brain sections; Cappell, Aurora, OH, USA) was applied for 1 h at room temperature, and then washed. The second secondary antibody (Vero cells: rhodamine-conjugated horse anti-rabbit antibody, 1:100; brain sections: Texas Red-conjugated goat anti-rabbit, 10 mg/ml) was applied for 1 h then washed. Cultures and brain sections were then viewed and photographed under an Olympus epifluorescence microscope (Sunnyvale, CA, USA).
Vector specificity: Two additional animals were injected with control vector into the hippocampus as described above. Brain sections were prepared and stained with Xgal (a chromogenic substrate for ␤gal) and cresyl violet. Adjacent sections were double immunofluorescence labeled as described above. Antibodies against neuronal (monoclonal anti-MAP2, 1:3000; Sigma) or astrocyte (GFAP, 1:1000; Sigma) markers were applied followed by antibodies against ␤gal. The number of double and single (␤gal only) labeled cells were counted from the three brain sections centered on the injection site.
Behavior Animals were food deprived and maintained at approximately 80% of their free-feeding weight for the duration of training. Rats were trained on a spatial delayed-alternation task conducted on a T-maze (100 cm × 15 cm arms, 15 cm walls). Pre-training began by exposing the animal to the maze with rewards scattered on the start arm, and both choice arms for two, 10 min sessions. On the second day of pre-training a block was placed at the entrance to each choice arm, alternating between sessions.
Each of the following training trials consisted of a sample phase and a choice phase. In the sample phase (1) a reward was placed in a cup at the end of both arms, (2) the left or right choice arm of the maze was blocked, and (3) the animal was placed in the start arm. The animal was, thus, forced in one direction to receive a reward. After consuming the reward, the block was removed and the animal was returned to the start arm for the choice phase. In the choice phase (1) a reward remained in the cup at the end of the previously blocked arm, and (2) the animal could receive the reward by selecting that arm. Six trials per day were conducted. On day 1, no delay intervened between the sample and choice phase to ensure that all animals could learn the alternation rule. On days 2-4, a 15-s delay intervened between the sample and choice trials. The number of errors (selecting the sample arm during the choice phase) was recorded. Rats were typically run for 3 days before they reached criterion performance of one or no errors, and then all animals in the experiment underwent surgery. Animals were then tested (six trials per day) 7 and 11 days after surgery to evaluate behavioral performance.
Surgery
Kainic acid (1.5 l of a 0.06 g/l solution; Sigma) was injected unilaterally via chronically implanted 25-gauge cannulae into the hippocampus of adult male SpragueDawley rats (250-300 g; Simonsen Labs, Gilroy, CA, USA) at the following stereotaxic coordinates: from bregma, AP −3.8, ML ±2.0 and DV −2.0 from surface. The injection needle extended 1 mm past the end of the guide cannulae. Calbindin or control vector was microinfused in 3 l of viral inoculum at the same coordinates bilaterally, immediately, 30 min, 1 h, or 4 h after toxin infusion.
Histology and analysis Animals that were killed 2 days after vector injection for the quantitative analysis of gene overexpression, or used to determine lesion size, underwent histology and analysis in the same way as those animals undergoing behavioral testing.
Following behavioral testing, animals were deeply anesthetized and perfused transcardially with 0.9% physiological saline followed by 4% paraformaldehyde. Brains were removed and post-fixed in a 4% paraformaldehyde/20% sucrose solution for approximately 24-48 h. After post-fixation brains were frozen, cut into 35 m sections on a cryostat, and every fourth section was mounted on gelatin-coated slides. Sections were then covered with a 5-bromo-4-chloro-3-indolyl-␤-d-galactopyranoside (X-gal) solution (Molecular Probes, Eugene, OR, USA) overnight to visualize expression of the reporter gene product ␤-galactosidase in order to determine the site of injection and amount and spread of the vector. Sections were then rinsed with tap water, allowed to dry, Nissl stained with cresyl violet, and coverslipped.
Cell loss in area CA3 was measured using a 10 × 10 grid in the ocular of the microscope at ×10 and counting the number of pixels with missing or damaged cells. Counts were taken from 10 coronal sections through the entire hippocampus at ෂ0.5 mm increments for each animal, performed blind with respect to which vector was infused. Data were then converted into volume measurements and an ANOVA was performed comparing data from the ␤-galactosidase and calbindin groups at each delay (immediate, 30 min, 1 h and 4 h).
Analysis of the behavioral data (number of errors) was performed using an ANOVA comparing scores on testing days for the immediate and 1-h delay groups.
To determine possible differences in the amount of infection and spread of the vector, the dentate gyrus from each of 10 serial coronal sections was divided into thirds (medial, middle and lateral). Measures were taken using the same calibrated grid in the ocular of the microscope, converted into number of neurons infected and recorded. An analysis of the differences in infection area between the immediate and 1-h delay groups was performed for medial to lateral spread and anterior to posterior spread. Separate analyses were performed to determine possible differences in lesion location between immediate and 1-h groups by dividing area CA3 in each of the 10 serial coronal sections into thirds (medial, middle and lateral). Counts of the number of pixels with damaged neurons were taken, converted into % of total lesion scores, recorded and analyzed. An anterior/posterior analysis of area CA3 lesion size differences between these two groups was also performed.
